Artemisinin resistance in plasmodium falciparum: A process linked to dormancy?

International Journal for Parasitology: Drugs and Drug Resistance

Volumn 2, Issue , 2012, Pages 249-255

  Cheng, Qin ^a,b   Kyle, Dennis E ^c   Gatton, Michelle L ^b  

^a AUSTRALIAN ARMY MALARIA INSTITUTE   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Artemisinin; Artemisinin resistance; Dormancy; Plasmodium falciparum; Treatment failure

Indexed keywords

ARTEMISININ; MEFLOQUINE;

ANTIMALARIAL DRUG RESISTANCE; ARTICLE; HUMAN; MALARIA; MALARIA CONTROL; MONOTHERAPY; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; TREATMENT FAILURE;

EID: 84873559086     PISSN: 22113207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpddr.2012.01.001     Document Type: Review

References (67)

1. Afonso, A., Hunt, P., Cheesman, S., Alves, A.C., Cunha, C.V., do, R.V., Cravo, P., 2006 Malaria parasites can develop stable resistance to artemisinin but lack mutations in candidate genes atp6 (encoding the sarcoplasmic and endoplasmic reticulum Ca2+ ATPase), tctp, mdr1, and cg10. Antimicrob. Agents Chemother. 50, 480-489
2. Anderson, T.J., Nair, S., Nkhoma, S., Williams, J.T., Imwong, M., Yi, P., Socheat, D., Das, D., Chotivanich, K., Day, N.P., White, N.J., Dondorp, A.M., 2010. High heritability of malaria parasite clearance rate indicates a genetic basis for artemisinin resistance in western Cambodia. J Infect Dis 201, 1326-1330
3. Angus, B.J., Chotivanich, K., Udomsangpetch, R., White, N.J., 1997. In vivo removal of malaria parasites from red blood cells without their destruction in acute falciparum malaria. Blood 90, 2037-2040
4. Balint, G.A., 2001. Artemisinin and its derivatives: an important new class of antimalarial agents. Pharmacol. Ther. 90, 261-265
5. Beez, D., Sanchez, C.P., Stein, W.D., Lanzer, M., 2011. Genetic predisposition favors the acquisition of stable artemisinin resistance in malaria parasites. Antimicrob Agents Chemother. 55, 50-55
6. Bhisutthibhan, J., Pan, X.Q., Hossler, P.A., Walker, D.J., Yowell, C.A., Carlton, J., Dame, J.B., Meshnick, S.R., 1998. The Plasmodium falciparum translationally controlled tumor protein homolog and its reaction with the antimalarial drug artemisinin J. Biol. Chem. 273, 16192-16198
7. Bjorkman, A., 2002. Malaria associated anaemia, drug resistance and antimalarial combination therapy. Int. J. Parasitol. 32, 1637-1643
8. Bray, P.G., Ward, S.A., O'Neill, P.M., 2005. Quinolines and artemisinin: chemistry, biology and history. Curr. Top. Microbiol. Immunol. 295, 3-38
9. Buffet, P.A., Milon, G., Brousse, V., Correas, J.M., Dousset, B., Couvelard, A., Kianmanesh, R., Farges, O., Sauvanet, A., Paye, F., Ungeheuer, M.N., Ottone, C., Khun, H., Fiette, L., Guigon, G., Huerre, M., Mercereau-Puijalon, O., David, P.H., 2006. Ex vivo perfusion of human spleens maintains clearing and processing functions. Blood 107, 3745-3752
10. Bwijo, B., Hassan, A.M., Abbas, N., Eriksson, O., Bjorkman, A., 1997. Repetitive dosing of artemisinin and quinine against Plasmodium falciparum in vitro: a simulation of the in vivo pharmacokinetics. Acta Trop. 65, 11-22
11. Chavchich, M., Gerena, L., Peters, J., Chen, N., Cheng, Q., Kyle, D.E., 2010. Role of pfmdr1 amplification and expression in induction of resistance to artemisinin derivatives in Plasmodium falciparum. Antimicrob. Agents Chemother. 54, 2455-2464
12. Chawira, A.N., Warhurst, D.C., Peters, W., 1986. Qinghaosu resistance in rodent malaria. Trans. R. Soc. Trop. Med. Hyg. 80, 477-480
13. Chen, N., Chavchich, M., Peters, J.M., Kyle, D.E., Gatton, M.L., Cheng, Q., 2010 Deamplification of pfmdr1-containing amplicon on chromosome 5 in Plasmodium falciparum is associated with reduced resistance to artelinic acid in vitro. Antimicrob. Agents Chemother. 54, 3395-3401
14. Codd, A., Teuscher, F., Kyle, D.E., Cheng, Q., Gatton, M.L., 2011. Artemisinin-induced parasite dormancy: a plausible mechanism for treatment failure. Malar. J. 10, 56
15. Cumming, J.N., Ploypradith, P., Posner, G.H., 1997. Antimalarial activity of artemisinin (qinghaosu) and related trioxanes: mechanism(s) of action. Adv Pharmacol. 37, 253-297
16. de Vries, P.J., Dien, T.K., 1996. Clinical pharmacology and therapeutic potential of artemisinin and its derivatives in the treatment of malaria. Drugs 52, 818-836
17. Ding, X.C., Beck, H.P., Raso, G., 2010. Plasmodium sensitivity to artemisinins: magic bullets hit elusive targets. Trends Parasitol. 27 (2), 73-81
18. Dondorp, A.M., Nosten, F., Yi, P., Das, D., Phyo, A.P., Tarning, J., Lwin, K.M., Ariey, F., Hanpithakpong, W., Lee, S.J., Ringwald, P., Silamut, K., Imwong, M., Chotivanich, K., Lim, P., Herdman, T., An, S.S., Yeung, S., Singhasivanon, P., Day, N.P., Lindegardh, N., Socheat, D., White, N.J., 2009. Artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 361, 455-467
19. Dutta, G.P., Bajpai, R., Vishwakarma, R.A., 1989. Artemisinin (qinghaosu)-a new gametocytocidal drug for malaria. Chemotherapy 35, 200-207
20. Gera, R., Khalil, A., 1997. Artemisinine and its derivatives. Indian Pediatr. 34, 813-816
21. Giao, P.T., Binh, T.Q., Kager, P.A., Long, H.P., Van Thang, N., Van Nam, N., de Vries, P.J., 2001. Artemisinin for treatment of uncomplicated falciparum malaria: is there a place for monotherapy? Am. J. Trop. Med. Hyg. 65, 690-695
22. Haynes, R.K., Krishna, S., 2004. Artemisinins: activities and actions. Microb. Infect. 6, 1339-1346
23. Hoshen, M.B., Na-Bangchang, K., Stein, W.D., Ginsburg, H., 2000. Mathematical modelling of the chemotherapy of Plasmodium falciparum malaria with artesunate: postulation of 'dormancy', a partial cytostatic effect of the drug, and its implications for treatment regimes. Parasitology 121, 237-246
24. Hunt, P., Afonso, A., Creasey, A., Culleton, R., Sidhu, A.B., Logan, J., Valderramos, S.G., McNae, I., Cheesman, S., Do, R.V., Carter, R., Fidock, D.A., Cravo, P., 2007. Gene encoding a deubiquitinating enzyme is mutated in artesunate- and chloroquine-resistant rodent malaria parasites. Mol. Microbiol. 65, 27-40
25. Inselburg, J., 1985. Induction and isolation of artemisinine-resistant mutants of Plasmodium falciparum. Am. J. Trop. Med. Hyg. 34, 417-418
26. Ittarat, W., Pickard, A.L., Rattanasinganchan, P., Wilairatana, P., Looareesuwan, S., Emery, K., Low, J., Udomsangpetch, R., Meshnick, S.R., 2003. Recrudescence in artesunate-treated patients with falciparum malaria is dependent on parasite burden not on parasite factors. Am. J. Trop. Med. Hyg. 68, 147-152
27. Jiang, G.F., 1992. In vitro development of sodium artesunate resistance in Plasmodium falciparum. Chung. Kuo. Chi. Sheng. Chung. Hsueh. Yu. Chi. Sheng Chung. Ping. Tsa. Chih. 10, 37-39
28. Kumar, N., Zheng, H., 1990. Stage-specific gametocytocidal effect in vitro of the antimalaria drug qinghaosu on Plasmodium falciparum. Parasitol. Res. 76, 214-218
29. Kyle, D.E., Webster, H.K., 1996. Postantibiotic effect of quinine and dihydroartemisin on Plasmodium falciparum in vitro: implications for a mechanism of recrudescence. In: XIVth International Congress for Tropical Medicine and Malaria, 1996
30. Kyle, D.E., Teja, I.P., Li, Q., Leo, K., 1998. Pharmacokinetics and pharmacodynamics of qinghaosu derivatives: how do they impact on the choice of drug and the dosage regimens? Med. Trop. Mars 58, 38-44
31. LaCrue, A.N., Scheel, M., Kennedy, K., Kumar, N., Kyle, D.E., 2011. Effects of artesunate on parasite recrudescence and dormancy in the rodent malaria model plasmodium vinckei. PLoS One 6, e26689
32. Li, Y., Wu, Y.L., 1998. How Chinese scientists discovered qinghaosu (artemisinin) and developed its derivatives? What are the future perspectives? Med. Trop Mars 58, 9-12
33. Looareesuwan, S., Wilairatana, P., Viravan, C., Vanijanonta, S., Pitisuttithum, P., Kyle, D.E., 1997. Open randomized trial of oral artemether alone and a sequential combination with mefloquine for acute uncomplicated falciparum malaria. Am J. Trop. Med. Hyg. 56, 613-617
34. McIntosh, H.M., Olliaro, P., 1999. Artemisinin derivatives for treating uncomplicated malaria. Cochrane Database Syst. Rev. 2, CD000256
35. Meshnick, S.R., Taylor, T.E., Kamchonwongpaisan, S., 1996. Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy Microbiol. Rev. 60, 301-315
36. Meshnick, S.R., 1998. Artemisinin antimalarials: mechanisms of action and resistance. Med. Trop. Mars 58, 13-17
37. Meshnick, S.R., 2002. Artemisinin: mechanisms of action, resistance and toxicity Int. J. Parasitol. 32, 1655-1660
38. Mok, S., Imwong, M., Mackinnon, M.J., Sim, J., Ramadoss, R., Yi, P., Mayxay, M., Chotivanich, K., Liong, K.-Y., Russell, B., Socheat, D., Newton, P.N., Day, N.P., White, N.J., Preiser, P.R., Nosten, F., Dondorp, A.M., Bozdech, Z., 2011 Artemisinin resistance in Plasmodium falciparum is associated with an altered temporal pattern of transcription. BMC Genomics 12, 391
39. Nakazawa, S., Kanbara, H., Aikawa, M., 1995. Plasmodium falciparum: recrudescence of parasites in culture. Exp. Parasitol. 81, 556-563
40. Nakazawa, S., Maoka, T., Uemura, H., Ito, Y., Kanbara, H., 2002. Malaria parasites giving rise to recrudescence in vitro. Antimicrob. Agents Chemother. 46, 958-965
41. Nguyen, D.S., Dao, B.H., Nguyen, P.D., Nguyen, V.H., Le, N.B., Mai, V.S., Meshnick, S.R., 1993. Treatment of malaria in Vietnam with oral artemisinin. Am. J. Trop. Med Hyg. 48, 398-402
42. Noedl, H., Se, Y., Schaecher, K., Smith, B.L., Socheat, D., Fukuda, M.M., 2008. Evidence of artemisinin-resistant malaria in western Cambodia. N. Engl. J. Med. 359, 2619-2620
43. Nosten, F., White, N.J., 2007. Artemisinin-based combination treatment of falciparum malaria. Am. J. Trop. Med. Hyg. 77, 181-192
44. Odenholt, I., Lowdin, E., Cars, O., 1997. Studies of the killing kinetics of benzylpenicillin, cefuroxime, azithromycin, and sparfloxacin on bacteria in the postantibiotic phase. Antimicrob. Agents Chemother. 41, 2522-2526
45. Olliaro, P.L., Taylor, W.R., 2004. Developing artemisinin based drug combinations for the treatment of drug resistant falciparum malaria: a review. J. Postgrad. Med 50, 40-44
46. Peters, W., 1990. The prevention of antimalarial drug resistance. Pharmacol. Ther 47, 499-508
47. Price, R.N., Nosten, F., Luxemburger, C., Ter-Kuile, F.O., Paiphun, L., Chongsuphajaisiddhi, T., White, N.J., 1996. Effects of artemisinin derivatives on malaria transmissibility. Lancet 347, 1654-1658
48. Price, R.N., Nosten, F., 2001. Drug resistant falciparum malaria: clinical consequences and strategies for prevention. Drug Resist. Updat. 4, 187-196
49. Saralamba, S., Pan-Ngum, W., Maude, R.J., Lee, S.J., Tarning, J., Lindegardh, N., Chotivanich, K., Nosten, F., Day, N.P., Socheat, D., White, N.J., Dondorp, A.M., White, L.J., 2010. Intrahost modeling of artemisinin resistance in Plasmodium falciparum. Proc. Natl. Acad. Sci. USA 108, 397-402
50. Targett, G., Drakeley, C., Jawara, M., von Seidlein, L., Coleman, R., Deen, J., Pinder, M., Doherty, T., Sutherland, C., Walraven, G., Milligan, P., 2001. Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae. J. Infect. Dis. 183, 1254-1259
51. Teuscher, F., Gatton, M.L., Chen, N., Peters, J., Kyle, D.E., Cheng, Q., 2010 Artemisinin-induced dormancy in Plasmodium falciparum: duration, recovery rates, and implications in treatment failure. J. Infect. Dis. 202, 1362-1368
52. Teuscher, F., Chen, N., Kyle, D.E., Gatton, M.L., Cheng, Q., 2012. Phenotypic changes in artemisinin resistant Plasmodium falciparum lines in vitro: evidence for decreased sensitivity to dormancy and growth inhibition. Antimicrob. Agents Chemother. 56, 428-431
53. Tjitra, E., Anstey, N.M., Sugiarto, P., Warikar, N., Kenangalem, E., Karyana, M., Lampah, D.A., Price, R.N., 2008. Multidrug-resistant plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. PLoS Med. 5, e128
54. Trape, J.F., Pison, G., Preziosi, M.P., Enel, C., Desgrees-du, L.A., Delaunay, V., Samb, B., Lagarde, E., Molez, J.F., Simondon, F., 1998. Impact of chloroquine resistance on malaria mortality. C. R Acad Sci III 321, 689-697
55. Tucker, M.S., Mutka, T., Sparks, K., Patel, J., Kyle, D.E., 2012. Phenotypic and genotypic analysis of in vitro selected artemisinin-resistant progeny of Plasmodium falciparum. Antimicrob. Agents Chemother. 56, 302-314
56. Uhlemann, A.C., Cameron, A., Eckstein-Ludwig, U., Fischbarg, J., Iserovich, P., Zuniga, F.A., East, M., Lee, A., Brady, L., Haynes, R.K., Krishna, S., 2005. A single amino acid residue can determine the sensitivity of SERCAs to artemisinins. Nat Struct. Mol. Biol. 12, 628-629
57. Warsame, M., Wernsdorfer, W.H., Ericsson, O., Bjorkman, A., 1990. Isolated malaria outbreak in Somalia: role of chloroquine-resistant Plasmodium falciparum demonstrated in Balcad epidemic. J. Trop. Med. Hyg. 93, 284-289
58. White, N.J., 1997. Assessment of the pharmacodynamic properties of antimalarial drugs in vivo. Antimicrob. Agents Chemother. 41, 1413-1422
59. White, N.J., 1998a. Preventing antimalarial drug resistance through combinations Drug Resist. Updat. 1, 3-9
60. White, N.J., 1998b. Qinghaosu in combinations. Med. Trop. Mars 58, 85-88
61. White, N.J., 1999. Delaying antimalarial drug resistance with combination chemotherapy. Parassitologia 41, 301-308
62. WHO, 2010a. Global report on antimalarial drug efficacy and drug resistance 2000-2010
63. WHO, 2010b. World malaria report 2010
64. Witkowski, B., Lelievre, J., Barragan, M.J., Laurent, V., Su, X.Z., Berry, A., Benoit-Vical, F., 2010. Increased tolerance to artemisinin in Plasmodium falciparum is mediated by a quiescence mechanism. Antimicrob. Agents Chemother. 54, 1872-1877
65. Yang, H., Gao, B., Huang, K., 1999. Comparison of sensitivity of artesunate-sensitive and artesunate-resistant Plasmodium falciparum to chloroquine and amodiaquine. Zhongguo Ji. Sheng Chong. Xue. Yu Ji Sheng Chong. Bing. Za Zhi 17, 353-355
66. Yang, H., Liu, D., Yang, Y., Fan, B., Yang, P., Li, X., Li, C., Dong, Y., Yang, C., 2003 Changes in susceptibility of Plasmodium falciparum to artesunate in vitro in Yunnan Province, China. Trans. R. Soc. Trop. Med. Hyg. 97, 226-228
67. Zucker, J.R., Lackritz, E.M., Ruebush, T.K., Hightower, A.W., Adungosi, J.E., Were, J.B., Metchock, B., Patrick, E., Campbell, C.C., 1996. Childhood mortality during and after hospitalization in western Kenya: effect of malaria treatment regimens Am. J. Trop. Med. Hyg. 55, 655-660